2don MSN
Legal questions swirl around FDA's new expedited drug program, including who should sign off
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
FDA nonmedical wearable health data devices providing general health info will not face regulation, clarifying guidance for ...
More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new ...
FDA Commissioner Dr. Marty Makary tells CBS News' Norah O'Donnell in an exclusive interview why the agency decided to drop decades-old "black box" warnings on many hormone therapy drugs used for ...
In an interview with Bloomberg News, Eli Lilly Chief Financial Officer Lucas Montarce said that the Indiana-based pharma ...
In a private speech to the FDA last week, Health Secretary Robert F. Kennedy Jr. made a series of comments that have people questioning his judgment. This was Kennedy’s first joint appearance with the ...
This week in Pedersen's POV, our senior editor argues against FDA's huge shift in digital health — made without public ...
The Food and Drug Administration (FDA) updated its guidance on Tuesday to allow more wearables to fall into a general ...
FDA plans limited regulation of wearable medical devices, boosting Apple, Fitbit, Oura stocks as 50% of Americans use fitness ...
The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback